Acurx Pharmaceuticals’ (NASDAQ: ACXP) mission in bringing to market an effective and durable treatment for C. difficile was provided a significant step forward. This time, it came as a result of yet another Phase 3 topline miss, with the late-stage clinical trial competitor Finch Therapeutics (NASDAQ: FNCH) reporting its terminating development stage programs for its […]
DelveInsight’s, “Psoriasis Pipeline Insight, 2023,” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Psoriasis pipeline landscape. It covers the Psoriasis pipeline drug profiles, including Psoriasis clinical trials and nonclinical stage products. It also covers the Psoriasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further […]
DelveInsight’s, “Osteosarcoma Pipeline Insight, 2023,” report provides comprehensive insights about 30+ Osteosarcoma companies and 30+ pipeline drugs in Osteosarcoma pipeline landscape. It covers the Osteosarcoma pipeline drug profiles, including Osteosarcoma clinical trials and nonclinical stage products. Osteosarcoma pipeline report also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It […]
Glioblastoma pipeline constitutes key companies continuously working towards developing Glioblastoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Glioblastoma Overview Grade IV glioblastomas are aggressive, malignant brain tumors that develop from the brain’s glial cells. Tumors with the potential to spread and infect adjacent cells are […]
Gastroesophageal Reflux Disease pipeline constitutes 9+ key companies continuously working towards developing 12+ Gastroesophageal Reflux Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Gastroesophageal Reflux Disease Overview The chronic gastrointestinal disorder gastroesophageal reflux disease (GERD) is defined by the regurgitation of stomach contents into the […]
Intuitive Surgical (US), Stryker Corporation (US), Medtronic Plc (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc. (UK) are key players in the surgical robots market. Browse 152 market data Tables and 52 Figures spread through 241 Pages and in-depth […]
The prominent players operating in the clinical trials market are IQVIA (US), LabCorp (US), Charles River Laboratories (US), WuXi AppTec (China), Syneos Health (US), PPD (US), and ICON Plc (US). Browse 324 market data Tables and 59 Figures spread through 304 Pages and in-depth TOC on “Clinical Trials Market – Global Forecast to 2026 Clinical […]
Despite weak markets, Avalon GloboCare (NASDAQ: ALBT) stock has been able to defend its valuation. Except for a late-day blip on Tuesday, ALBT shares have been consolidating at the $3.40 level, which from current prices and ALBT having enough accretive ammo to reclaim consolidation levels, puts an 11% gain in investors’ crosshairs. Of course, long-term […]
Some of the prominent players in the Cell & gene therapy manufacturing services market are Lonza (Switzerland), Catalent (US), Thermo Fisher Scientific (US), Charles River Laboratories (US WuXi AppTec (China), Merck KGaA (Germany) Browse 458 market data Tables and 47 Figures spread through 376 Pages and in-depth TOC on “Cell & Gene Therapy Manufacturing Services […]
The prominent players in this market are Oracle Corporation (US), Parexel International Corporation (US), Dassault Systèmes (France), Clario (US), Datatrak International (US), Signant Health (US), 4G Clinical (US), MaxisIT (US), IBM Watson Health (US) Browse 362 market data Tables and 38 Figures spread through 307 Pages and in-depth TOC on “eClinical Solutions Market by Product […]
